Catalyst OrthoScience has filed a notice of an exempt offering of securities to raise $5 Million in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Catalyst OrthoScience is raising up to $5,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Carl Oconnell played a…
